C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 5/12 (2006.01) A61K 38/00 (2006.01) A61K 38/05 (2006.01) A61P 31/14 (2006.01) C07K 5/08 (2006.01) C07K 5/083 (2006.01) C07K 5/087 (2006.01) C12N 9/50 (2006.01)
Patent
CA 2667266
The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections. (I)
La présente invention concerne des composés macrocycliques de formule (I) qui sont utilisables en tant qu'inhibiteurs de la protéase NS3 du virus de l'hépatite C (Hepatitis C Virus : HCV), leur synthèse et leur utilisation pour le traitement ou la prévention des infections par le HCV. (I)
Liverton Nigel J.
Mccauley John A.
Romano Joseph J.
Rudd Michael T.
Vacca Joseph P.
Gowling Lafleur Henderson Llp
Merck & Co. Inc.
Merck Sharp & Dohme Corp.
LandOfFree
Hcv ns3 protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hcv ns3 protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hcv ns3 protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1724573